Randomized, controlled crossover study of IVIg for demyelinating polyneuropathy and diabetes

OBJECTIVE: To determine whether IV immunoglobulin (IVIg) is more effective than placebo at reducing disability in patients with diabetes and demyelinating polyneuropathy features. METHODS: This is a double-blinded, single-center, randomized, controlled crossover trial of IVIg treatment vs placebo. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Breiner, Ari, Barnett Tapia, Carolina, Lovblom, Leif Erik, Perkins, Bruce A., Katzberg, Hans D., Bril, Vera
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943235/
https://www.ncbi.nlm.nih.gov/pubmed/31454771
http://dx.doi.org/10.1212/NXI.0000000000000586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943235/
https://www.ncbi.nlm.nih.gov/pubmed/31454771
http://dx.doi.org/10.1212/NXI.0000000000000586

Ejemplares similares